Fibroblast |
Dynamic stress |
3‐day cyclic loading, 0.1 Hz |
Enhanced proliferation, skin substitute production |
[227] |
Matrix stretching |
Cyclic equibiaxial stretching (7%, 15%, or 20% at 1 Hz) |
Increased collagen production, α‐SMA expression |
[231] |
2–16% cyclic stretch, 6 or 24 h day−1, 8 days |
Increased collagen density |
[228] |
Compression |
5, 15, 25, 35 g cm−2, 24 h |
Max proliferation at 25 g cm−2
|
[340] |
Epithelial cell |
Stretching |
20% strain, 45 min, 0.5 Hz |
Cell reorientation (transverse to stretching direction) |
[258] |
10%‐strain stretching |
Epithelial crack and healing |
[259] |
0–15% cyclic strain, 0.2 Hz |
Increased cell–cell interaction |
[260] |
Compression |
Loaded with 150 g weights |
Improve skin reconstitution |
[341] |
Endothelial cell |
Flow‐induced shear stress |
>10 dyn cm−2
|
Sprouting, matrix invasion |
[342] |
20 dynes cm−2 steady shear |
Reduced endothelial‐to‐mesenchymal transition |
[325] |
1.2 Pa laminar fluid shear |
Retarded elongation, alignment |
[330] |
Mesenchymal stem cell |
Compression |
10% peak compressive sinusoidal strain, 1 Hz, 5% compressive tare strain |
Enhanced chondrogenic differentiation, survival |
[196] |
0–2.5% strain, 1 Hz, 1‐h ON +23‐h OFF |
Distinct collagen expression, mineral deposits |
[197] |
10 kPa, 0.25 Hz, 1 h day−1, start day 1 or 21 |
Regulated chondrocyte markers, hypertrophy |
[199] |
Stretching |
±1%/2 days, 4–16%, 50% ON/OFF (3, 6, or 9 h) |
Optimal regime for MSC matrix production |
[190] |
Vibration |
0.3, 3, or 6 g loads, 100 Hz |
Enhanced osteogenesis (low/medium), inhibited (high) |
[173] |
Force loading |
1.6 pN per microparticle, 0.1 Hz |
Increased MSC behaviors, osteogenesis, reduced chondrogenesis |
[153] |